Inventor · disambiguated record
Atsushi Kimbara
Also filed as: KIMBARA ATSUSHI
16 granted patents·3 pending applications·86 citations·filing 2012–2025
92Inventor score
Top patents by PatentIndex Score
19 records- 0189US9593123B2Triazolo[4,5-D]pyrimidine derivativesHOFFMANN LA ROCHE·Filed 2016·Granted Mar 14, 2017·5 cites·14 claims
- 0289US9522886B2Pyridine derivativesHOFFMANN LA ROCHE·Filed 2013·Granted Dec 20, 2016·7 cites·18 claims
- 0389US9321727B2Pyridine derivatives as agonists of the CB2 receptorBISSANTZ CATERINA·Filed 2012·Granted Apr 26, 2016·19 cites·4 claims
- 0485US9056866B2[1,2,3]triazolo[4,5-D]pyrimidine derivativesHOFFMANN LA ROCHE·Filed 2014·Granted Jun 16, 2015·7 cites·46 claims
- 0584US10308659B2Pyridine derivativesHOFFMANN LA ROCHE·Filed 2015·Granted Jun 4, 2019·6 cites·10 claims
- 0684US9694012B2Pyrazol derivativesHOFFMANN LA ROCHE·Filed 2016·Granted Jul 4, 2017·4 cites·14 claims
- 0782US9409866B2Pyridine-2-amides useful as CB2 agonistsHOFFMANN LA ROCHE·Filed 2013·Granted Aug 9, 2016·7 cites·19 claims
- 0882US9303012B2Pyridine-2-amides useful as CB2 agonistsHOFFMANN LA ROCHE·Filed 2013·Granted Apr 5, 2016·8 cites·16 claims
- 0982US8741906B2[1,2,3]triazolo[4,5-D]pyrimidine derivativesHOFFMANN LA ROCHE·Filed 2012·Granted Jun 3, 2014·5 cites·30 claims
- 1081US9505762B2Purine derivatives as CB2 receptor agonistsHOFFMANN LA ROCHE·Filed 2015·Granted Nov 29, 2016·4 cites·13 claims
- 1181US9067943B2[1,2,3]triazolo[4,5-D]pyrimidine derivativesHOFFMANN LA ROCHE·Filed 2012·Granted Jun 30, 2015·5 cites·13 claims
- 1278US9512132B2Pyrazole compounds as CB2 agonistsHOFFMANN LA ROCHE·Filed 2015·Granted Dec 6, 2016·4 cites·16 claims
- 1377US9580435B2Pyrrolo[2,3-D]pyrimidine derivatives as CB2 receptor agonistsHOFFMAN-LA ROCHE INC·Filed 2015·Granted Feb 28, 2017·4 cites·11 claims
- 1467US9499553B2Dihydropyridazine-3,5-dione derivative and pharmaceuticals containing the sameCHUGAI PHARMACEUTICAL CO LTD·Filed 2015·Granted Nov 22, 2016·1 cites·47 claims
- 1566US2025084093A1Nitrogen-containing heterocyclic compound having nrf2 activation effectCHUGAI PHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
- 1665US12441735B2Nitrogen-containing heterocyclic compound having NRF2 activation effectCHUGAI PHARMACEUTICAL CO LTD·Filed 2025·Granted Oct 14, 2025·0 cites·28 claims
- 1751US2019248803A1Novel pyridine derivativesHOFFMANN LA ROCHE·Filed 2019·Application pending·0 cites
- 1847US9090615B2Adamantyl derivatives as cannabinoid receptor 2 agonistsHOFFMANN LA ROCHE·Filed 2014·Granted Jul 28, 2015·0 cites·23 claims
- 1942US2016137606A1Novel pyridine derivativesHOFFMANN LA ROCHE·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Atsushi Kimbara files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →